SARAH UEBELHOER: Open Payments
NPI 1528345469 · MAYVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,775 in 95 payments from 25 companies in 2025. Trend: 2023 $2,354 · 2024 $2,075 · 2025 $1,775
Food & beverage: $1,775
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $253 |
| Lilly USA, LLC | 14 | $248 |
| GlaxoSmithKline, LLC. | 15 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $162 |
| Novo Nordisk Inc | 9 | $160 |
| ABBVIE INC. | 4 | $77 |
| Boston Scientific Corporation | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Astellas Pharma US Inc | 2 | $57 |
| Axsome Therapeutics, Inc. | 2 | $55 |
Products named: TRELEGY ELLIPTA, CAPLYTA, NURTEC ODT, JARDIANCE, MOUNJARO, Wegovy, VRAYLAR, ELIQUIS.
Industry payments across NY — which companies pay providers there.
